Crossmark

A clinicopathological and molecular series of five TFEB-altered renal cell carcinoma (RCC) cases: highlighting an aggressive subset of TFEB-rearranged RCC concomitant with TFEB amplification/gene copy number gains

Crossref DOI link: https://doi.org/10.1007/s00428-024-03968-5

Published Online: 2024-11-10

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Minhua

Wang, Ruifen

Guan, Wenbin

Jiang, Ruiqi

Wang, Kezhou

Liu, Yi

Wang, Lifeng
License Information

Text and Data Mining valid from 2024-11-10

Version of Record valid from 2024-11-10
More Information

Article History

Received: 24 June 2024

Revised: 14 October 2024

Accepted: 1 November 2024

First Online: 10 November 2024

Declarations

:

: This study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine. All investigations were conducted according to the principles listed in the Declaration of Helsinki.

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below